2Lookingbill DP, Spangler N,Helm KF.Cutaneous metastases in patients with metastatic carcinoma:a retrospective study of 4020 patients.J Am Acad Dermatol,1993(29):228-236.
3Maida V,Corbo M,Dolzhykov M,et al.Wounds in advanced illness:a prevalence and incidence study based on a prospective case series.lnt Wound J,2008(5): 305-314.
4Grocott P,Gethinb G,Probst S.Malignant wound management in advanced illness:new insights.Curr Opin Support Palliat Care,2013,7( 1 ):101 - 105.
5Probst S,Arber A,Faithful S.Malignant fungating wounds-The meaning of living in an unbounded body. European Journal of Oncology Nursing,2013(17):38-45.
6Gethin G,Grocott P, Pmbst S,et al.Current practice in the management of wound malodour:an international survey.Vienna:European Wound Management Association, 2012.
7Shu FL,Hayter M,Hu WY, et aI.Symptom burden and quality of life in patients with malignant fungating wounds.Journal of advanced nursing,2011,9(3):1312- 1321.
8Haughton W, Young T.Common problems in wound care:malodorous wounds.Br J Nuts,1995,4(16):959-963.
9Grocott P.Developing a tool for researching fungating wounds. [2013-10-31].http://www.worldwide wounds.com/2001/july/Groeott/Fungating- Wounds. html.
10Cristina M,Cibele A,Moacyr R.A systematic review of topical treatments to control the odor of malignant fungating wounds.Journal of Pain and Symptom Management ,2010,39(6):1065-1076.
